PORT WASHINGTON, N.Y., May 30, 2012 (GLOBE NEWSWIRE) -- Aceto Corporation (Nasdaq:ACET), a global leader in the marketing, sales and distribution of pharmaceutical active ingredients and intermediates, finished dosage form generic pharmaceuticals, nutraceutical products, agricultural protection products and specialty chemicals today announced its new Logo and renamed Business Segments. The following announcement from Albert Eilender, Chairman and CEO, was sent to Aceto Shareholders on May 29, 2012.
As you can see from the new logo, we are introducing a number of enhancements to our corporate appearance. Not only is there a new logo but there also will shortly be a newly designed website, www.ACETO.com.
When you visit and explore our redesigned electronic home you will find improved navigation and enhancements relating to our core competencies of sourcing, regulatory support and quality assurance that apply to each of the three business segments within our international framework of operations.
We have also reconfigured and renamed our three business segments to better reflect today's ACETO. The six individual business units that make up the overall company have not changed only their prominence, location and placement within the newly designated segments.
The three newly named business segments are:
- Human Health- consists of Nutritional and Finished Dosage Form products.
- Pharmaceutical Ingredients- consists of Active Pharmaceutical Ingredients, and Intermediates.
- Performance Chemicals- consists of Specialty Chemicals and Agricultural Protection products.
This reconfiguration does not impact our relationships with our customer and/or supplier base. Functionally, we have aligned our senior management team to better support the newly named business segments resulting in no change to our operating costs. Rather, this realignment is intended to provide a clearer lens through which our Company can be viewed by our diverse stakeholders, spanning our customers, suppliers, employees, shareholders and the people within the communities where we have active business establishments. The new business segments will provide a more accurate intellectual and visual understanding of how the Aceto business has evolved, and how it should be viewed as we move forward. To provide additional clarity at fiscal year-end, we will report our financials within these newly named segments, as well as for the previous two years.
We encourage you to explore our new website which will be fully operational by the start of our new fiscal year. It should be intuitive, easy to navigate, and the clarity of our core competencies of sourcing, regulatory support and quality assurance, combined with our marketing, sales and distribution effort across all of our business segments, should be self-evident. Sections covering Investor Relations, Governance, and Career Opportunities will have all been enhanced.
I would also like to acknowledge the creative participation of our employees in both the design of our logo and drafting of the web site copy. By doing the bulk of the work internally we have been able to limit our cost to outside 3rd parties to a minimal amount of monies, less than $50,000, which is a notable accomplishment.
We trust that you will find that collectively these changes enhance the understanding of Aceto both substantively and aesthetically.
ABOUT ACETO
Aceto Corporation, incorporated in 1947, is a global leader in the marketing and distribution of pharmaceutical intermediates and active ingredients, finished dosage form generics, nutraceutical products, agricultural protection products and specialty chemicals. With business operations in nine countries, Aceto distributes over 1,100 chemical compounds used principally as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical consuming industries. Aceto's global operations, including a staff of 26 in China and 12 in India are distinctive in the industry and enable its worldwide sourcing and regulatory capabilities. (ACET-F)
CONTACT:
Amy Glynn
The Ruth Group
(646) 536-7023
[email protected]